PAREint: Testing a Novel Parenting Intervention for Children With Autism

Sponsor
City, University of London (Other)
Overall Status
Recruiting
CT.gov ID
NCT04574206
Collaborator
(none)
50
1
2
22
2.3

Study Details

Study Description

Brief Summary

This study will investigate the acceptability and preliminary effectiveness of training parents to use a structured communication intervention that is aimed towards helping children with autism spectrum disorder (ASD).

This intervention has demonstrated benefits for non-autistic children in known areas of difficulty found with autistic individuals. There are currently few evidence-based interventions for school-aged children with ASD who have no other language or intellectual disabilities and are educated in mainstream schools. We will evaluate the benefits of training parents to use a freely available communication technique designed to tackle underlying psychological processes crucial to later development.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Elaborative Reminiscence (ER)
  • Behavioral: Present Tense Talk (PTT)
N/A

Detailed Description

Over recent years a growing body of research has reported significant, beneficial effects of using an "elaborative reminiscence" (ER) intervention on a range of typically-developing child outcomes including memory language skills, emotional understanding and understanding of mind. A recently published 9- year follow-up study further indicates that these benefits are longstanding. This has prompted speculation that ER could be a beneficial intervention for children with neurodevelopmental disorders who have known difficulties in these areas. To date, no studies have assessed the benefits of using ER as an intervention for ASD.

This study aims to evaluate the feasibility, acceptability and preliminary effectiveness of training parents to use ER as an intervention for high-functioning children with ASD. This study will use a two-arm, parallel-group, randomised controlled design to compare a parent-delivered ER intervention against a control intervention (present tense talk).

Fifty parent-child dyads (comprising children with ASD and IQ >70) will be recruited from mainstream schools, specialist unit/ schools, or relevant organisations (25 dyads per trial arm). Primary outcomes will be NIHR-recognised quantitative indicators of feasibility and acceptability for the ER condition.This will include (yet is not limited to) exploring the feasibility of methods of recruiting participants, feasibility of administering outcome assessments at baseline and follow-up, feasibility of delivering the training for ER and PTT remotely (i.e. through video conferencing), the feasibility of parents delivering ER or PTT in their home setting, and the acceptability of ER to parents. Parent acceptability of ER will be assessed using a daily logbook questionnaire and post-trial interviews, based on the Theoretical Framework of Acceptability.

Secondary outcomes will be measures of clinical and functional outcomes for both experimental conditions. Descriptive measures of general intelligence, vocabulary and developmental level will be administered at baseline for both experimental conditions (ER and PTT) and used to describe the participant sample. Outcome measures for child memory, mental state understanding, and self-concept will be administered at baseline and again after 20 weeks to assess change or response to the interventions. Differences in parent reminiscing style from baseline to post-trial will be assessed for all participants to assess the success of intervention training.

On completion of follow-up outcome assessments, parents in the ER condition will be invited to participate in a single qualitative interview to evaluate the acceptability of the ER intervention and study procedures. Interviews will be based on the Theoretical Framework of Acceptability and the Necessity-Concerns Framework.

Descriptive statistics will be taken for indicators of intervention feasibility and acceptability.Comparisons between the two trial arms will be made using inferential statistical analysis for multiple outcomes, whilst adjusting for covariates.

In response to the present Covid-19 situation, this study will take place remotely. All interaction with participants (recruitment and data collection and participant testing) will use video software (e.g. Zoom, AdobeConnect, MS Teams), or online surveys (e.g. Qualtrics). Data analysis will either take place in the Autism Research Unit laboratory, located at City University of London, or remotely via a secure network.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This is a two-arm, randomised pilot study to compare a caregiver-delivered elaborative reminiscence intervention against a control intervention for children with autism spectrum disorder, aged 7-11 years. Randomisation will occur at the participant level and participants will be allocated to the trial arms using a 1:1 ratio.This is a two-arm, randomised pilot study to compare a caregiver-delivered elaborative reminiscence intervention against a control intervention for children with autism spectrum disorder, aged 7-11 years. Randomisation will occur at the participant level and participants will be allocated to the trial arms using a 1:1 ratio.
Masking:
Single (Participant)
Masking Description:
The study will be single-blinded at the participant level, however if further funding is obtained then the study will be double-blinded to include blinding at the researcher level.
Primary Purpose:
Supportive Care
Official Title:
Developing and Evaluating a Parent-child Intervention for Intellectually Able Children With Autism Spectrum Disorders: A Feasibility Study
Actual Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Elaborative Reminiscence (ER)

ER is a communication strategy used between a caregiver and child to support children's cognitive and emotional development. ER involves a caregiver and child jointly reminiscing about a past event that they personally experienced, to co-create a coherent narrative that describes the event from both their perspectives. ER consists of two crucial elements, the use of elaborative language (e.g. open ended questions, contributing new information to the conversation) and specific talk focused on recollections of the past as opposed to observations of the present.

Behavioral: Elaborative Reminiscence (ER)
Parents will be trained to use elaborative communication techniques in conversations with their child.

Sham Comparator: Present Tense Talk (PTT)

PTT is an active control intervention, designed to ensure that caregivers/ guardians in this group spend a similar amount of time engaging in conversation with their children but do not use elaborative reminiscing language. The focus will be on describing activities as they are happening in real time; PTT caregivers will be asked to avoid reference future or past events .

Behavioral: Present Tense Talk (PTT)
Parents will be trained to engage their children in conversations, describing activities as they are actually happening.

Outcome Measures

Primary Outcome Measures

  1. Trial recruitment feasibility [20 weeks post-trial]

    The number of participants who dropped out of the trial as a percentage of the total number recruited.

  2. Feasibility of training procedures [Baseline]

    Percentage of participants who demonstrate 70% or more of intervention behaviours during the training roleplay assessment.

  3. Training enactment [Change from baseline to 20 weeks post-trial]

    Change to caregiver reminiscing style ratio following training

  4. Implementation fidelity (actual dosage) [20 weeks post-trial]

    The actual number of intervention behaviours caregivers demonstrate during conversations at post-trial.

  5. Implementation fidelity (frequency of intervention delivery) [20 weeks post-trial]

    The mean number of intervention minutes delivered by caregivers

  6. Intervention acceptability [20 weeks post-trial]

    A qualitative analysis (guided by the Theoretical Framework of Acceptability) of post-trial caregiver interviews to determine caregiver acceptability of the ER intervention.

Secondary Outcome Measures

  1. Memory test [Change from baseline to 20 weeks post-trial]

    Change to child scores on the California Verbal Learning Test for Children (CVLT-C)

  2. Memory elaborations [Change from baseline to 20 weeks post-trial]

    Number of child memory elaborations during parent-child conversations

  3. Mental state understanding [Change from baseline to 20 weeks post-trial]

    Change to child scores on the Theory of Mind Battery

  4. Self-concept [Change from baseline to 20 weeks post-trial]

    Change to child scores on the Self-Description Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 11 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Caregivers and children:
  1. Must have access to a digital device capable of receiving video calls (e.g. smartphone, tablet or computer) and internet

  2. Must primarily speak in English, as assessed with a pre-screening survey question.

Children only:
  1. Aged 7-11 years

  2. Diagnostic status i) Documented clinical diagnosis of ASD provided by caregivers or schools (e.g. a diagnostic report), OR ii) Meeting cut off for autism on the Social Communication Questionnaire (i.e. Score above or equal to 15 on SCQ)

  3. Intelligence within the average range or above as measured by the Raven's Coloured Progressive Matrices (ie minimum IQ within 2 SD below the mean).

  4. Developmental and linguistic levels within the average range as measured by the Vineland Adaptive Behaviour Scales (VABS-3) and the British Picture Vocabulary Scale (BPVS).

Exclusion Criteria:
Caregivers and children:
  1. Must not currently be receiving care or treatment for a mental or psychiatric condition
  2. Must not be currently taking part in another research study

Contacts and Locations

Locations

Site City State Country Postal Code
1 City University of London London Greater London United Kingdom EC1V 0HB

Sponsors and Collaborators

  • City, University of London

Investigators

  • Study Director: Anna Ramberg, City, University of London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
City, University of London
ClinicalTrials.gov Identifier:
NCT04574206
Other Study ID Numbers:
  • GRY190053860
First Posted:
Oct 5, 2020
Last Update Posted:
Jan 28, 2021
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 28, 2021